Macy's jumps after guidance and financing update Check out this morning's top movers from around Wall Street, compiled by The Fly.
UP AFTER EARNINGS AND GUIDANCE -
- Macy's (M) up 8%
- Tiffany (TIF) up 2%
- Lovesac (LOVE) up 10%
ALSO HIGHER -
- Amphastar Pharmaceuticals (AMPH) up 6% after the FDA approved its Abbreviated New Drug Application for Succinylcholine Chloride Injection
- Immunic (IMUX) up 2% after the receipt of regulatory allowance from the FDA to initiate its phase 2, CALVID-1 clinical trial of IMU-838, the company's selective oral DHODH inhibitor, in COVID-19 patients
DOWN AFTER EARNINGS -
ALSO LOWER -
- Soleno Therapeutics (SLNO) down 46% after the company's Phase 3 trial, DESTINY PWS, evaluating once-daily Diazoxide Choline Controlled Release, or DCCR, tablets for patients with Prader-Willi Syndrome, or PWS, did not meet its primary endpoint of change from baseline in hyperphagia
Symbols:
M TIF SIG - $16.90 /
+1.845 (+12.26%)
LOVE AMPH IMUX SLNO Keywords: Fly Intel, Wall Street, Top Stories, Stocks